DE60137368D1 - Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren - Google Patents
Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahrenInfo
- Publication number
- DE60137368D1 DE60137368D1 DE60137368T DE60137368T DE60137368D1 DE 60137368 D1 DE60137368 D1 DE 60137368D1 DE 60137368 T DE60137368 T DE 60137368T DE 60137368 T DE60137368 T DE 60137368T DE 60137368 D1 DE60137368 D1 DE 60137368D1
- Authority
- DE
- Germany
- Prior art keywords
- gsα
- antidepressiva
- markers
- therapy
- associated methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5035—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on sub-cellular localization
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5058—Neurological cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9466—Antidepressants
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/726—G protein coupled receptor, e.g. TSHR-thyrotropin-receptor, LH/hCG receptor, FSH
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22187400P | 2000-07-29 | 2000-07-29 | |
PCT/US2001/023851 WO2002010763A2 (en) | 2000-07-29 | 2001-07-30 | Marker for antidepressant therapy and methods related thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60137368D1 true DE60137368D1 (de) | 2009-02-26 |
Family
ID=22829768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60137368T Expired - Lifetime DE60137368D1 (de) | 2000-07-29 | 2001-07-30 | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren |
Country Status (7)
Country | Link |
---|---|
US (4) | US6875566B2 (de) |
EP (1) | EP1356292B1 (de) |
AT (1) | ATE420361T1 (de) |
AU (2) | AU2001277222B2 (de) |
CA (1) | CA2417578C (de) |
DE (1) | DE60137368D1 (de) |
WO (1) | WO2002010763A2 (de) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE420361T1 (de) * | 2000-07-29 | 2009-01-15 | Univ Illinois | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren |
US11218291B2 (en) | 2018-02-26 | 2022-01-04 | Stmicroelectronics (Rousset) Sas | Method and circuit for performing a substitution operation |
FR3078463A1 (fr) | 2018-02-26 | 2019-08-30 | Stmicroelectronics (Rousset) Sas | Procede et dispositif de realisation d'operations en table de substitution |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6034071A (en) * | 1994-09-16 | 2000-03-07 | Iyengar; Srinivas Ravi V. | Mutant activated GS α and adenylyl cyclase 2 for use as therapeutic agents |
US6107076A (en) * | 1995-10-04 | 2000-08-22 | Board Of Regents, The University Of Texas System | Soluble mammalian adenylyl cyclase and uses therefor |
IL116205A0 (en) * | 1995-11-30 | 1996-01-31 | Univ Ben Gurion | Methods and kits for diagnosis and monitoring treatments of psychiatric disorders |
US6071722A (en) * | 1998-04-24 | 2000-06-06 | Smithkline Beecham Corporation | Nucleic acids encoding a G-protein coupled 7TM receptor (AXOR-1) |
US20020061599A1 (en) * | 1999-12-30 | 2002-05-23 | Elling Christian E. | Method of identifying ligands of biological target molecules |
ATE420361T1 (de) * | 2000-07-29 | 2009-01-15 | Univ Illinois | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren |
US6448377B1 (en) * | 2000-09-27 | 2002-09-10 | The Board Of Trustees Of The Leland Stanford Junior University | Modified G protein sunbunits |
US20040209808A1 (en) * | 2003-02-11 | 2004-10-21 | Kornacker Michael G. | Modulators of human G-protein coupled receptors |
-
2001
- 2001-07-30 AT AT01955013T patent/ATE420361T1/de not_active IP Right Cessation
- 2001-07-30 DE DE60137368T patent/DE60137368D1/de not_active Expired - Lifetime
- 2001-07-30 EP EP01955013A patent/EP1356292B1/de not_active Expired - Lifetime
- 2001-07-30 AU AU2001277222A patent/AU2001277222B2/en not_active Ceased
- 2001-07-30 CA CA002417578A patent/CA2417578C/en not_active Expired - Fee Related
- 2001-07-30 US US09/918,230 patent/US6875566B2/en not_active Expired - Lifetime
- 2001-07-30 AU AU7722201A patent/AU7722201A/xx active Pending
- 2001-07-30 WO PCT/US2001/023851 patent/WO2002010763A2/en active Application Filing
-
2005
- 2005-02-08 US US11/053,516 patent/US7118858B2/en not_active Expired - Lifetime
-
2006
- 2006-09-29 US US11/529,944 patent/US7445888B2/en not_active Ceased
-
2010
- 2010-11-04 US US12/939,550 patent/USRE43712E1/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
AU2001277222B2 (en) | 2006-05-04 |
US7118858B2 (en) | 2006-10-10 |
AU7722201A (en) | 2002-02-13 |
WO2002010763A3 (en) | 2003-08-28 |
US20070026385A1 (en) | 2007-02-01 |
CA2417578C (en) | 2008-07-15 |
ATE420361T1 (de) | 2009-01-15 |
EP1356292B1 (de) | 2009-01-07 |
US20050153388A1 (en) | 2005-07-14 |
EP1356292A2 (de) | 2003-10-29 |
US6875566B2 (en) | 2005-04-05 |
CA2417578A1 (en) | 2002-02-07 |
USRE43712E1 (en) | 2012-10-02 |
US20020039752A1 (en) | 2002-04-04 |
WO2002010763A2 (en) | 2002-02-07 |
US7445888B2 (en) | 2008-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE298890T1 (de) | Gewebeinhibitor der matrix-metalproteinase typ 1 (timp-1) als krebsmarker | |
DE60238058D1 (de) | Verwendung von lysyloxydase inhibitoren zur zellkultur und gewebeaufbau | |
ATE360989T1 (de) | Präzise wirksamkeitsbestimmungsmethode für wirkstoffe einschliesslich chemotherapeutika | |
DE60012716D1 (de) | Neue halbleiternanopartikel zur analyse von blutzellpopulationen | |
DE69941429D1 (de) | 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a | |
ATE469219T1 (de) | Zusammensetzungen, methoden und reagentien zur nukleinsäureisolierung mittels oberflächenaktiven substanzen und proteasen | |
DE60031939D1 (de) | Als Quelle und Responder betreibbare ATM-Prüfvorrichtung zur Ausführung von mehreren Tests | |
BR0207775A (pt) | Lipossomos anfotéricos métodos para carregamento dos mesmos com ingredientes ativos e sua utilização | |
GT200000002AA (es) | Ureas difenilicias x-carboxiaril sustituidas como inhibidores de raf quinasa | |
ECSP045520A (es) | Metodos de tratamiento con inhibidores de la ptec y agentes antihipertensivos | |
DE59912716D1 (de) | Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür | |
DE60239059D1 (de) | Verfahren und zusammensetzungen zur hemmung, prävention oder verringerung des tumorzellwachstums beingen einer antiöstrogen-therapie resistent sind | |
ATE473273T1 (de) | Angereicherte zellpopulationen des zentralen nervensystems | |
AR030718A1 (es) | Proteinas de bacillus thuringiensis inhibidoras de insectos fusiones y metodos de uso de las mismas | |
DE60137368D1 (de) | Marker für therapie mit antidepressiva und damit in zusammenhang stehende verfahren | |
ATE333510T1 (de) | Enzymatische messung von mycophenolsäure | |
WO2004016766A3 (en) | Real time measurement of cellular responses | |
DE60012140D1 (de) | Verwendung von urintrypsininhibitor zur diagnose von aids | |
BR9606821A (pt) | Processo de racemização para uso na fabricação de levobupivacaina e agentes anestésicos correlacionados de piperidina carboxanilida | |
ATE277352T1 (de) | Einetenascin-c isoform als marker für neoplasmen | |
ATE386935T1 (de) | Verfahren zur auswahl bioaktiver wirkstoffe durch lumineszenzkopplung und lebendes zellensystem dafür | |
DE60225587D1 (de) | Protease assay zur kontrolle medikamentöser therapie | |
ATE470856T1 (de) | Gleichzeitigen flusszytometrischer messungen von die inhibition der zellproliferation und der toxizität | |
BR0115689A (pt) | Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata | |
WO2003058251A3 (en) | Toxicity test |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |